Global Active Pharmaceutical Ingredients Market Report 2024

Active Pharmaceutical Ingredients Global Market Report 2024 – By Type (Innovative APIs (Active Pharmaceutical Ingredient), Generic APIs (Active Pharmaceutical Ingredient)), By Manufacturer (Captive Manufacturers, Merchant Manufacturers ), By Type Of Drug (Prescription Drugs, Over-The-Counter Drugs ), By Therapeutic Application (Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Pain Management, Respiratory Diseases, Other Therapeutic Applications) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 200 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Active Pharmaceutical Ingredients Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Active Pharmaceutical Ingredients Market Definition And Segments

The active pharmaceutical ingredient (API) is any component or substance used in a finished pharmaceutical product (FPP) and is designed to have pharmacological action or otherwise have a direct impact on the treatment, mitigation, cure, or prevention of disease. It is also used for the restoration, correction, or modification of human physiological processes.

The main types of active pharmaceutical ingredients are innovative APIs (active pharmaceutical ingredient), and generic APIs (active pharmaceutical ingredient). Innovative APIs refer to a drug containing an active ingredient or ingredient combination that has never before been approved. Innovative APIs are used to provide patients with unique treatments for illnesses for which there are no effective treatments on the market. The type of manufacturers include captive manufacturers, and merchant manufacturers with synthesis types such as synthetic APIs (active pharmaceutical ingredient), and biotech APIs (active pharmaceutical ingredient). These are used in prescription drugs, and over-the-counter drugs in therapeutic applications such as communicable diseases, oncology, diabetes, cardiovascular disease, pain management, respiratory diseases, and others.

The active pharmaceutical ingredients market covered in this report is segmented –

1) By Type: Innovative APIs (Active Pharmaceutical Ingredient), Generic APIs (Active Pharmaceutical Ingredient)

2) By Manufacturer: Captive Manufacturers, Merchant Manufacturers

3) By Type Of Drug: Prescription Drugs, Over-The-Counter Drugs

4) By Therapeutic Application: Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Pain Management, Respiratory Diseases, Other Therapeutic Applications

The active pharmaceutical ingredients market size has grown strongly in recent years. It will grow from $218.45 billion in 2023 to $233.55 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to advancements in drug development, expansion of generic drug market, globalization of pharmaceutical manufacturing, regulatory initiatives for drug safety, rise in contract manufacturing organizations (CMOs), focus on precision medicine, emergence of biopharmaceuticals, global pandemics and health threats.

The active pharmaceutical ingredients market size is expected to see strong growth in the next few years. It will grow to $305.2 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing healthcare expenditure, increasing focus on rare diseases, expansion of biosimilars market, advancements in green chemistry, focus on continuous manufacturing, regulatory support for innovation, globalization of clinical trials, focus on sustainable and ethical practices. Major trends in the forecast period include digitalization of drug development, investment in advanced manufacturing technologies, APIs for rare diseases and orphan drugs, regulatory scrutiny on quality, API serialization and traceability, biopharmaceuticals and biotechnology products.

Rising Chronic Disease Incidence Fuels Growth In The Active Pharmaceutical Ingredients Market

The increasing incidence of chronic diseases is expected to propel the growth of the active pharmaceutical ingredients market going forward. Chronic disease is one that often lasts for three months or longer and may worsen with time. Cancer, heart disease, stroke, diabetes, and arthritis are the most prevalent chronic diseases. APIs are used in high-quality medications that address oncology, cardiology, neurology, orthopedic, and other illnesses. For instance, according to IDF Diabetes Atlas published by the International Diabetes Federation (IDF), a Belgium-based global organization to advocate for the global treatment, control, and cure of diabetes, by 2030, the number of people with diabetes is expected to increase to 578 million, and 700 million by 2045. Nearly half of deaths from diabetes occur in adults under the age of 60, making it one of the top 10 killers. Therefore, increasing incidence of chronic diseases will drive the growth of the active pharmaceutical ingredients market.

Elevated Research And Development Investment Propels Active Pharmaceutical Ingredients Market Growth

The increasing investment in research and development (R&D) is expected to propel the growth of the active pharmaceutical ingredients market going forward. Investment in research and development (R&D) refers to the allocation of resources, including financial, human, and technological, towards activities aimed at creating new knowledge, developing innovative products, services, or processes, and improving existing offerings. Investment in research and development (R&D) plays a crucial role in the development of active pharmaceutical ingredients (APIs) by fostering innovation, enhancing product quality, and driving progress in the pharmaceutical industry. Biopharmaceutical companies and government agencies invest in R&D to develop innovative APIs and formulations, aiming to improve treatment outcomes and address unmet medical needs. For instance, in September 2023, according to the National Center for Science and Engineering Statistics, a US-based principal statistical agency, federal agency commitments for research and experimental development (R&D) in FY 2021 increased by 13.6% ($22.7 billion) from those in FY 2020, which were $167.4 billion, to an all-time high of $190.2 billion (in current dollars). Therefore, the increasing investment in research and development (R&D) is driving the growth of the active pharmaceutical ingredients market.

Major companies operating in the active pharmaceutical ingredients market report are Albemarle Corporation, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, AbbVie Inc., Teva Pharmaceutical Industries Limited, Cipla Limited, Boehringer Ingelheim International GmbH, Merck KGaA, Sun Pharmaceutical Industries Limited, Bristol-Myers Squibb Company, Mylan Pharmaceuticals ULC, BASF Corporation, Lupin Limited, Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Pfizer Inc., Novartis International AG, Sanofi S.A, Viatris Inc., Cadila Pharmaceuticals Limited, Amneal Pharmaceuticals Inc., Apotex Inc., Sun Pharmaceutical Industries Ltd., Lonza Group AG, HPM Chemicals and Fertilizers Ltd., GlaxoSmithKline PLC, Godrej Consumer Products, Roche Holding AG, Daiichi Sankyo Inc., Catalent Inc.

Technological Advancements Revolutionize Active Pharmaceutical Ingredients Market Manufacturing Processes

Technological advancement in the active pharmaceutical ingredients market is a key trend gaining popularity in the active pharmaceutical ingredients market. Major companies operating in the market are focusing on implementing innovative technologies and methods in the optimized production of APIs such as continuous flow chemistry, advancements in lyophilization, powder handling, and process control to sustain their position in the market. For instance, in May 2022, the companies such as NovAliX, a France-based clinical research organization focused on drug discovery, ALYSOPHIL SAS, a France-based developer of an innovative industrial strategy based on continuous flow chemistry, De Dietrich Process Systems, a France-based global provider of engineered systems, process solutions, and process equipment and Bruker, a US-based developer, producer, and seller of high-performance scientific equipment as well as analytical and diagnostic solutions have partnered to introduce an innovative method for producing active pharmaceutical ingredients (APIs). The PIPAc (Production Intelligente de Principes Actifs) project, which is based on a Smart Production of Active Ingredients model, aims to advance API manufacturing by severing the lengthy and frequently complex supply chains connected with pharmaceutical production and developing rapid-response mobile API production units that are prepared for global deployment. PIPAc will develop next-generation, autonomous, and optimized unit by fusing cutting-edge synthesis, continuous flow chemistry, and in-flow analysis with artificial intelligence.

Innovative Solutions Driving Revenue Growth In Active Pharmaceutical Ingredients Market

Major companies operating in the active pharmaceutical ingredients market are focused on introducing innovative solutions, such as Capsugel Enprotect, to drive their revenues in the market. An innovative Active Pharmaceutical Ingredient (API) solution refers to a novel and advanced pharmaceutical compound that serves as the biologically active component in a drug product. For instance, in November 2022, Lonza Group AG, a Switzerland-based manufacturing company for pharmaceuticals and biotechnology, launched Capsugel Enprotect, an innovative new capsule solution to deliver acid-sensitive active pharmaceutical ingredients to the intestine. Capsugel Enprotect, the first ever coating-free capsule to support intestinal delivery of acid-sensitive APIs, helps speed up first-in-human timescales for medication development by streamlining the manufacturing process. The capsule does not disintegrate during stomach transit and only releases its contents in the intestine. The novel delivery method is intended for use with tiny molecules, proteins, peptides, and RNA-based medicines. Additionally, it will facilitate the delivery of living biotherapeutic products—a novel and cutting-edge class of medical interventions.

Aceto Strengthens Drug Development Support With Acquisition Of Cascade Chemistry

In June 2021, Aceto, a US-based supplier of specialty materials for the health sciences and high-tech end markets, acquired Cascade Chemistry for an undisclosed amount. With this acquisition, Aceto expects to provide its clients better support throughout the drug development process and easier access to expanded North American manufacturing, especially for APIs and advanced intermediates. Cascade Chemistry is a US-based contract development and manufacturing organization (CDMO) and a manufacturer of active pharmaceutical ingredients.

North America was the largest region in the active pharmaceutical ingredients market share in 2023. The regions covered in the active pharmaceutical ingredients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the active pharmaceutical ingredients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The active pharmaceutical ingredient market consists of sales of active pharmaceutical ingredients that are used in final pharmaceutical products such as drug products (tablet, pill, cream, or injectable) to deliver a desired effect. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The active pharmaceutical ingredients market research report is one of a series of new reports from The Business Research Company that provides active pharmaceutical ingredients market statistics, including active pharmaceutical ingredients industry global market size, regional shares, competitors with an active pharmaceutical ingredients market share, detailed active pharmaceutical ingredients market segments, market trends and opportunities, and any further data you may need to thrive in the active pharmaceutical ingredients industry. This active pharmaceutical ingredients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Active Pharmaceutical Ingredients Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $233.55 billion
Revenue Forecast In 2033 $305.2 billion
Growth Rate CAGR of 6.9% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Innovative APIs (Active Pharmaceutical Ingredient), Generic APIs (Active Pharmaceutical Ingredient)
2) By Manufacturer: Captive Manufacturers, Merchant Manufacturers
3) By Type Of Drug: Prescription Drugs, Over-The-Counter Drugs
4) By Therapeutic Application: Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Pain Management, Respiratory Diseases, Other Therapeutic Applications
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Albemarle Corporation; Aurobindo Pharma Limited; Dr. Reddy's Laboratories Limited; AbbVie Inc.; Teva Pharmaceutical Industries Limited; Cipla Limited; Boehringer Ingelheim International GmbH; Merck KGaA; Sun Pharmaceutical Industries Limited; Bristol-Myers Squibb Company; Mylan Pharmaceuticals ULC; BASF Corporation; Lupin Limited; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche AG; Pfizer Inc.; Novartis International AG; Sanofi S.A; Viatris Inc.; Cadila Pharmaceuticals Limited; Amneal Pharmaceuticals Inc.; Apotex Inc.; Sun Pharmaceutical Industries Ltd.; Lonza Group AG; HPM Chemicals and Fertilizers Ltd.; GlaxoSmithKline PLC; Godrej Consumer Products; Roche Holding AG; Daiichi Sankyo Inc.; Catalent Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Active Pharmaceutical Ingredients  Market Characteristics

    3. Active Pharmaceutical Ingredients  Market Trends And Strategies

    4. Active Pharmaceutical Ingredients  Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Active Pharmaceutical Ingredients  Market Size and Growth

    5.1. Global Active Pharmaceutical Ingredients  Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Active Pharmaceutical Ingredients  Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Active Pharmaceutical Ingredients  Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Active Pharmaceutical Ingredients  Market Segmentation

    6.1. Global Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Innovative APIs (Active Pharmaceutical Ingredient)

    Generic APIs (Active Pharmaceutical Ingredient)

    6.2. Global Active Pharmaceutical Ingredients  Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Captive Manufacturers

    Merchant Manufacturers  

    6.3. Global Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Prescription Drugs

    Over-The-Counter Drugs  

    6.4. Global Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Communicable Diseases

    Oncology

    Diabetes

    Cardiovascular Disease

    Pain Management

    Respiratory Diseases

    Other Therapeutic Applications

    7. Active Pharmaceutical Ingredients  Market Regional And Country Analysis

    7.1. Global Active Pharmaceutical Ingredients  Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Active Pharmaceutical Ingredients  Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Active Pharmaceutical Ingredients  Market  

    8.1. Asia-Pacific Active Pharmaceutical Ingredients  Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Active Pharmaceutical Ingredients  Market  

    9.1. China Active Pharmaceutical Ingredients  Market Overview  

    9.2. China Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Active Pharmaceutical Ingredients  Market  

    10.1. India Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Active Pharmaceutical Ingredients  Market  

    11.1. Japan Active Pharmaceutical Ingredients  Market Overview  

    11.2. Japan Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Active Pharmaceutical Ingredients  Market  

    12.1. Australia Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Active Pharmaceutical Ingredients  Market  

    13.1. Indonesia Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Active Pharmaceutical Ingredients  Market  

    14.1. South Korea Active Pharmaceutical Ingredients  Market Overview  

    14.2. South Korea Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Active Pharmaceutical Ingredients  Market  

    15.1. Western Europe Active Pharmaceutical Ingredients  Market Overview

    15.2. Western Europe Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Active Pharmaceutical Ingredients  Market  

    16.1. UK Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Active Pharmaceutical Ingredients  Market  

    17.1. Germany Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Active Pharmaceutical Ingredients  Market  

    18.5. France Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Active Pharmaceutical Ingredients  Market  

    19.9. Italy Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Active Pharmaceutical Ingredients  Market  

    20.13. Spain Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Active Pharmaceutical Ingredients  Market  

    21.1. Eastern Europe Active Pharmaceutical Ingredients  Market Overview

    21.2. Eastern Europe Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Active Pharmaceutical Ingredients  Market  

    22.1. Russia Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Active Pharmaceutical Ingredients  Market  

    23.1. North America Active Pharmaceutical Ingredients  Market Overview

    23.2. North America Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Active Pharmaceutical Ingredients  Market  

    24.1. USA Active Pharmaceutical Ingredients  Market Overview

    24.2. USA Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Active Pharmaceutical Ingredients  Market  

    25.1. Canada Active Pharmaceutical Ingredients  Market Overview

    25.2. Canada Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Active Pharmaceutical Ingredients  Market  

    26.1. South America Active Pharmaceutical Ingredients  Market Overview

    26.2. South America Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Active Pharmaceutical Ingredients  Market  

    27.1. Brazil Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Active Pharmaceutical Ingredients  Market  

    28.1. Middle East Active Pharmaceutical Ingredients  Market Overview

    28.2. Middle East Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Active Pharmaceutical Ingredients  Market  

    29.1. Africa Active Pharmaceutical Ingredients  Market Overview

    29.2. Africa Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Active Pharmaceutical Ingredients  Market Competitive Landscape And Company Profiles

    30.1. Active Pharmaceutical Ingredients  Market Competitive Landscape

    30.2. Active Pharmaceutical Ingredients  Market Company Profiles

    30.2.1. Albemarle Corporation

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Aurobindo Pharma Limited

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Dr. Reddy's Laboratories Limited

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. AbbVie Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Teva Pharmaceutical Industries Limited

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Active Pharmaceutical Ingredients  Market Competitive Benchmarking

    32. Global Active Pharmaceutical Ingredients  Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Active Pharmaceutical Ingredients  Market

    34. Active Pharmaceutical Ingredients  Market Future Outlook and Potential Analysis

    34.1 Active Pharmaceutical Ingredients  Market In 2028 - Countries Offering Most New Opportunities

    34.2 Active Pharmaceutical Ingredients  Market In 2028 - Segments Offering Most New Opportunities

    34.3 Active Pharmaceutical Ingredients  Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Active Pharmaceutical Ingredients  Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Active Pharmaceutical Ingredients  Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Active Pharmaceutical Ingredients  Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Albemarle Corporation Financial Performance
  • Table 76: Aurobindo Pharma Limited Financial Performance
  • Table 77: Dr. Reddy's Laboratories Limited Financial Performance
  • Table 78: AbbVie Inc. Financial Performance
  • Table 79: Teva Pharmaceutical Industries Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Active Pharmaceutical Ingredients  Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Active Pharmaceutical Ingredients  Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Active Pharmaceutical Ingredients  Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Active Pharmaceutical Ingredients  Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Active Pharmaceutical Ingredients  Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Active Pharmaceutical Ingredients  Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Albemarle Corporation Financial Performance
  • Figure 76: Aurobindo Pharma Limited Financial Performance
  • Figure 77: Dr. Reddy's Laboratories Limited Financial Performance
  • Figure 78: AbbVie Inc. Financial Performance
  • Figure 79: Teva Pharmaceutical Industries Limited Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2024 – By Product( Antiparasitic, Anti-Infectives, Vaccines, NSAIDs), By Service Type( In House, Contract Outsourcing), By Synthesis Type( Chemical Based API, Biological API, Highly Potent API) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pharmaceutical API Manufacturing Global Market Report 2024 – By Therapy Area (Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, Other Therapeutics Uses), By API Type (Chemical API, Biological API), By Drug Type (Prescription Drugs, Over-The-Counter (OTC) Drugs) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2024 – By Type (Contract Manufacturing Services, Contract Research Services), By Research Phase (Preclinical, Phase I, Phase II, Phase III, Phase IV), By End User (Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pharmaceutical Sterility Testing Global Market Report 2024 – By Sample (Sterile Drugs, Medical Devices, Biologics and Therapeutics), By Product Type (Instruments, Kits and Reagents, Services), By Type (In- house, Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, Bacterial Endotoxin Testing), By End- User (Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pharmaceutical Excipients Global Market Report 2024 – By Product (Inorganic Chemicals, Organic Chemicals, Other Products), By Functionality (Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities), By Type Of Formulation (Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pharmaceutical Drugs Global Market Report 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Disease Drugs, Vaccine And Therapeutic Nutrients, Minerals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter (OTC) Drugs, Prescription-Based Drugs) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pharmaceutical Processing Seals Global Market Report 2024 – By Type (O-rings, Gaskets, Lip seals, D seals, Other types (Diaphragms and X-rings)), By Material (Metals, PTFE, Silicone, Nitrile Rubber, EPDM, Other materials), By Application (Manufacturing Equipment, Agitators, Mixers, Reactors, Gear Boxes, Other applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pharmaceuticals Global Market Report 2022 – By Type (Pharmaceutical Drugs, Biologics), By Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, E-Commerce), By Nature (Organic, Conventional) – Market Size, Trends, And Global Forecast 2022-2026
View Report

Frequently Asked Questions

What is the definition of the active pharmaceutical ingredients market?

The active pharmaceutical ingredient (API) is any component or substance used in a finished pharmaceutical product (FPP) and is designed to have pharmacological action or otherwise have a direct impact on the treatment, mitigation, cure, or prevention of disease. It is also used for the restoration, correction, or modification of human physiological processes. For further insights on the active pharmaceutical ingredients market, request a sample here

How will the active pharmaceutical ingredients market drivers and restraints affect the active pharmaceutical ingredients market dynamics? What forces will shape the active pharmaceutical ingredients industry going forward?

The active pharmaceutical ingredients market major growth driver - rising chronic disease incidence fuels growth in the active pharmaceutical ingredients market. For further insights on the active pharmaceutical ingredients market, request a sample here

What is the forecast market size or the forecast market value of the active pharmaceutical ingredients market ?

The active pharmaceutical ingredients market size has grown strongly in recent years. It will grow from $218.45 billion in 2023 to $233.55 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to advancements in drug development, expansion of generic drug market, globalization of pharmaceutical manufacturing, regulatory initiatives for drug safety, rise in contract manufacturing organizations (cmos), focus on precision medicine, emergence of biopharmaceuticals, global pandemics and health threats. The active pharmaceutical ingredients market size is expected to see strong growth in the next few years. It will grow to $305.2 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing healthcare expenditure, increasing focus on rare diseases, expansion of biosimilars market, advancements in green chemistry, focus on continuous manufacturing, regulatory support for innovation, globalization of clinical trials, focus on sustainable and ethical practices. Major trends in the forecast period include digitalization of drug development, investment in advanced manufacturing technologies, apis for rare diseases and orphan drugs, regulatory scrutiny on quality, api serialization and traceability, biopharmaceuticals and biotechnology products. For further insights on the active pharmaceutical ingredients market, request a sample here

How is the active pharmaceutical ingredients market segmented?

The active pharmaceutical ingredients market is segmentedThe active pharmaceutical ingredients market covered in this report is segmented –
1) By Type: Innovative APIs (Active Pharmaceutical Ingredient), Generic APIs (Active Pharmaceutical Ingredient)
2) By Manufacturer: Captive Manufacturers, Merchant Manufacturers
3) By Type Of Drug: Prescription Drugs, Over-The-Counter Drugs
4) By Therapeutic Application: Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Pain Management, Respiratory Diseases, Other Therapeutic ApplicationsFor further insights on the active pharmaceutical ingredients market, request a sample here

Which region has the largest share of the active pharmaceutical ingredients market? What are the other regions covered in the report?

North America was the largest region in the active pharmaceutical ingredients market share in 2023. The regions covered in the active pharmaceutical ingredients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the active pharmaceutical ingredients market, request a sample here.

Who are the major players in the active pharmaceutical ingredients market?

Major companies operating in the active pharmaceutical ingredients market report are Albemarle Corporation, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, AbbVie Inc., Teva Pharmaceutical Industries Limited, Cipla Limited, Boehringer Ingelheim International GmbH, Merck KGaA, Sun Pharmaceutical Industries Limited, Bristol-Myers Squibb Company, Mylan Pharmaceuticals ULC, BASF Corporation, Lupin Limited, Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Pfizer Inc., Novartis International AG, Sanofi S.A, Viatris Inc., Cadila Pharmaceuticals Limited, Amneal Pharmaceuticals Inc., Apotex Inc., Sun Pharmaceutical Industries Ltd., Lonza Group AG, HPM Chemicals and Fertilizers Ltd., GlaxoSmithKline plc, Godrej Consumer Products, Roche Holding AG, Daiichi Sankyo Inc., Catalent Inc. For further insights on the active pharmaceutical ingredients market, request a sample here.

What are the key trends in the active pharmaceutical ingredients market?

Major trend in the active pharmaceutical ingredients market - technological advancements revolutionize active pharmaceutical ingredients market manufacturing processes. For further insights on the active pharmaceutical ingredients market, request a sample here.

What are the major opportunities in the active pharmaceutical ingredients market? What are the strategies for the active pharmaceutical ingredients market?

For detailed insights on the major opportunities and strategies in the active pharmaceutical ingredients market, request a sample here.

How does the active pharmaceutical ingredients market relate to the overall economy and other similar markets?

For detailed insights on active pharmaceutical ingredients market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the active pharmaceutical ingredients industry?

For detailed insights on the mergers and acquisitions in the active pharmaceutical ingredients industry, request a sample here.

What are the key dynamics influencing the active pharmaceutical ingredients market growth? SWOT analysis of the active pharmaceutical ingredients market.

For detailed insights on the key dynamics influencing the active pharmaceutical ingredients market growth and SWOT analysis of the active pharmaceutical ingredients industry, request a sample here.